BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 35 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $310,000 | -22.9% | 206,912 | -0.2% | 0.00% | – |
Q4 2015 | $402,000 | -2.0% | 207,230 | 0.0% | 0.00% | – |
Q3 2015 | $410,000 | -2.1% | 207,230 | +2.4% | 0.00% | – |
Q2 2015 | $419,000 | +0.2% | 202,364 | +11.5% | 0.00% | – |
Q1 2015 | $418,000 | +8.9% | 181,544 | +6.0% | 0.00% | – |
Q4 2014 | $384,000 | -7.0% | 171,285 | +2.4% | 0.00% | – |
Q3 2014 | $413,000 | -14.7% | 167,307 | -1.5% | 0.00% | – |
Q2 2014 | $484,000 | -53.8% | 169,888 | -0.8% | 0.00% | -100.0% |
Q1 2014 | $1,047,000 | +47.7% | 171,289 | +1.2% | 0.00% | 0.0% |
Q4 2013 | $709,000 | -1.0% | 169,189 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $716,000 | -25.5% | 171,189 | -40.6% | 0.00% | 0.0% |
Q2 2013 | $961,000 | – | 288,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 729,781 | $2,080,000 | 1.97% |
Healthcare Value Capital, LLC | 145,507 | $415,000 | 0.35% |
Broadfin Capital, LLC | 2,244,266 | $6,396,000 | 0.32% |
TOWERVIEW LLC | 225,000 | $641,000,000 | 0.31% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 360,668 | $1,028,000 | 0.22% |
Dominick & Dominick LLC | 146,016 | $416,000 | 0.20% |
BVF INC/IL | 435,900 | $1,242,000 | 0.20% |
Perceptive Advisors | 253,400 | $722,000 | 0.07% |
BAILARD, INC. | 115,000 | $328,000 | 0.05% |
KNOTT DAVID M | 88,100 | $251,085,000 | 0.04% |